论文部分内容阅读
由于体重异常和月经功能不良有关,作者在102个月经过少的妇女中,研究体重对诱发排卵所需的克罗米芬剂量的影响。根据体重与身高计算体重指数(BMI),BMI=体重(公斤)/〔身高(米)〕~2。克罗米芬治疗开始时总量为250mg,如未发生排卵则增加剂量;如BMI有适当改变,或有副作用发生,则减量或停药。根据妊娠、双相基温及分泌期子宫内膜确定,有90%的妇女发生排卵。未能排卵者BMI在18以下或28以上。总量在250mg或250mg以上而达到排卵者占显著多数。BMI在21～27之间的妇女用这一剂量达到排卵是极常见的。BM I在21～27范围内变化的30名妇女均发生排卵,其中9人恢复自然的有
Due to abnormal body weight and poor menstrual function, the authors studied the effect of body weight on the dose of clomiphene required to induce ovulation in 102-month-old women. Body mass and height based on body mass index (BMI), BMI = body weight (kg) / [height (m)] ~ 2. Clomiphene At the beginning of the treatment of the total amount of 250mg, if no increase in ovulation dose; such as BMI with appropriate changes, or side effects occur, the reduction or withdrawal. According to pregnancy, bipolar temperature and secretory endometrium identified, 90% of women ovulation. Ovulation BMI below 18 or above 28. The total number of 250mg or 250mg or more to achieve ovulation accounted for a significant majority. It is extremely common for women with BMI between 21 and 27 to achieve ovulation at this dose. Ovulation occurred in 30 women with BM I varying from 21 to 27, of whom 9 returned to normal